Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Choroidal neovascularisation: Which Medications Are Safest? (45 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

45 medications are used for Choroidal neovascularisation, with 5,152 combined adverse event reports. The most reported drugs for Choroidal neovascularisation are AFLIBERCEPT and RANIBIZUMAB.

5,152
Total Reports
45
Drugs Used

All Medications for Choroidal neovascularisation Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
AFLIBERCEPT EYLEA 2,953 8,527 3,193 31.7%
RANIBIZUMAB CIMERLI 1,364 2,651 2,265 17.3%
FARICIMAB\FARICIMAB-SVOA - 306 97 79 2.9%
BEVACIZUMAB JOBEVNE 302 17,498 23,114 22.4%
BROLUCIZUMAB-DBLL - 104 198 170 7.1%
BROLUCIZUMAB BEOVU 102 41 105 6.0%
FARICIMAB-SVOA - 65 175 169 9.2%
VERTEPORFIN Visudyne 42 19 46 2.5%
AVASTIN - 12 606 328 36.4%
LUCENTIS - 11 184 180 26.8%
TRIAMCINOLONE ACETONIDE Triamcinolone Acetonide 10 1,874 3,276 11.2%
FARICIMAB VABYSMO 8 23 98 6.0%
EYLEA - 7 200 53 49.3%
FLUOCINOLONE ACETONIDE fluocinolone acetonide 7 11 82 0.6%
MYCOPHENOLATE MOFETIL Mycophenolate mofetil 6 13,776 25,831 18.4%
AZATHIOPRINE AZATHIOPRINE 5 4,579 10,817 13.8%
DEXAMETHASONE\NEOMYCIN\POLYMYXIN B - 5 2 49 0.3%
TRIAMCINOLONE - 5 369 1,419 5.5%

View all 45 drugs →

Most Reported Drugs for Choroidal neovascularisation

#1 most reported
#2 most reported
#3 most reported